About Stericycle (NASDAQ:SRCL)
Stericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company's segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.
Industry, Sector and Symbol
Industry BUSINESS SERVICES
Sub-IndustryEnvironmental & Facilities Services
Trailing P/E Ratio244.586330243471
Forward P/E Ratio13.88
Sales & Book Value
Annual Sales$3.58 billion
Price / Sales1.52
Cash Flow$7.53 per share
Price / Cash8.44
Book Value$34.07 per share
Price / Book1.87
Net Income$42.40 million
Return on Equity13.83%
Return on Assets5.61%
Stericycle (NASDAQ:SRCL) Frequently Asked Questions
What is Stericycle's stock symbol?
Stericycle trades on the NASDAQ under the ticker symbol "SRCL."
How were Stericycle's earnings last quarter?
Stericycle Inc (NASDAQ:SRCL) announced its quarterly earnings data on Wednesday, February, 21st. The business services provider reported $1.00 EPS for the quarter, missing the Zacks' consensus estimate of $1.14 by $0.14. The business services provider earned $887.80 million during the quarter, compared to the consensus estimate of $882.62 million. Stericycle had a return on equity of 13.83% and a net margin of 1.18%. Stericycle's revenue was down 2.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.00 EPS. View Stericycle's Earnings History.
When will Stericycle make its next earnings announcement?
What guidance has Stericycle issued on next quarter's earnings?
Stericycle issued an update on its FY18 earnings guidance on Wednesday, February, 21st. The company provided earnings per share guidance of $4.45-4.85 for the period, compared to the Thomson Reuters consensus estimate of $4.63. The company issued revenue guidance of $3.48-3.63 billion, compared to the consensus revenue estimate of $3.64 billion.
Where is Stericycle's stock going? Where will Stericycle's stock price be in 2018?
9 equities research analysts have issued 1-year target prices for Stericycle's shares. Their forecasts range from $10.00 to $100.00. On average, they expect Stericycle's stock price to reach $68.88 in the next twelve months. View Analyst Ratings for Stericycle.
Who are some of Stericycle's key competitors?
Some companies that are related to Stericycle include TransUnion (TRU), The Western Union (WU), Interpublic Group of Companies (IPG), Smiths Group (SMGZY), DCC (DCCPF), FactSet Research Systems (FDS), Edenred (EDNMY), ManpowerGroup (MAN), Xerox (XRX), Robert Half International (RHI), Black Knight (BKI), Rentokil Initial (RTOKY), WEX (WEX), Genpact (G), Oc Oerlikon (OERLF), Booz Allen Hamilton (BAH), Ingenico Group (INGIY) and Dun & Bradstreet (DNB).
Who are Stericycle's key executives?
Stericycle's management team includes the folowing people:
- Mark C. Miller, Chairman of the Board (Age 61)
- Charles A. Alutto, President, Chief Executive Officer, Director (Age 51)
- Daniel V. Ginnetti, Chief Financial Officer, Executive Vice President (Age 48)
- Brent Arnold, Chief Operating Officer, Executive Vice President (Age 48)
- John P. Schetz, Executive Vice President, General Counsel (Age 40)
- Ruth-Ellen Abdulmassih, Executive Vice President and President, Communication & Related Services (Age 55)
- Michael J. Collins, Executive Vice President, President - Recall and Returns Management Services (Age 59)
- Brenda Frank, Executive Vice President, Chief People Officer (Age 47)
- Richard J. Hoffman, Senior Vice President, Chief Accounting Officer (Age 50)
- Jack W. Schuler, Lead Independent Director (Age 76)
Has Stericycle been receiving favorable news coverage?
Headlines about SRCL stock have been trending somewhat positive recently, according to Accern. The research group scores the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Stericycle earned a news impact score of 0.16 on Accern's scale. They also gave media coverage about the business services provider an impact score of 45.35 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
Who are Stericycle's major shareholders?
Stericycle's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include
PRICE T ROWE ASSOCIATES INC
(10.00%), BlackRock Inc. (6.37%), Wells Fargo & Company MN (3.31%), Fairpointe Capital LLC (2.72%), Clarkston Capital Partners LLC (2.35%) and Jennison Associates LLC (1.73%). Company insiders that own Stericycle stock include Jack W Schuler, John P Schetz, Mark C Miller, Mike S Zafirovski, Robert S Murley and Rodney F Dammeyer. View Institutional Ownership Trends for Stericycle.
Which major investors are selling Stericycle stock?
SRCL stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Millennium Management LLC, Teacher Retirement System of Texas, Two Sigma Investments LP, Deutsche Bank AG, Renaissance Technologies LLC, Zurcher Kantonalbank Zurich Cantonalbank and State of Wisconsin Investment Board. View Insider Buying and Selling for Stericycle.
Which major investors are buying Stericycle stock?
SRCL stock was purchased by a variety of institutional investors in the last quarter, including Clarkston Capital Partners LLC, Wells Fargo & Company MN, Mondrian Investment Partners LTD, Sterling Capital Management LLC, Global Thematic Partners LLC, Amundi Pioneer Asset Management Inc., Champlain Investment Partners LLC and Raymond James & Associates. Company insiders that have bought Stericycle stock in the last two years include Jack W Schuler, Mike S Zafirovski and Robert S Murley. View Insider Buying and Selling for Stericycle.
How do I buy shares of Stericycle?
Shares of SRCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Stericycle's stock price today?
One share of SRCL stock can currently be purchased for approximately $63.59.
How big of a company is Stericycle?
Stericycle has a market capitalization of $5.44 billion and generates $3.58 billion in revenue each year. The business services provider earns $42.40 million in net income (profit) each year or $0.26 on an earnings per share basis. Stericycle employs 645 workers across the globe.
How can I contact Stericycle?
Stericycle's mailing address is 28161 NORTH KEITH DRIVE, LAKE FOREST IL, 60045. The business services provider can be reached via phone at 847-367-5910 or via email at [email protected]
MarketBeat Community Rating for Stericycle (SRCL)MarketBeat's community ratings are surveys of what our community members think about Stericycle and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Stericycle (NASDAQ:SRCL) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Hold||Hold||Hold||Hold|
|Consensus Rating Score: ||2.44||2.36||2.33||2.31|
|Ratings Breakdown: ||1 Sell Rating(s)|
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
5 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
5 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$68.88||$72.44||$73.40||$80.91|
|Price Target Upside: ||8.31% upside||1.51% upside||9.06% upside||12.22% upside|
Stericycle (NASDAQ:SRCL) Consensus Price Target History
Stericycle (NASDAQ:SRCL) Analyst Ratings History
(Data available from 3/18/2016 forward)
Stericycle (NASDAQ:SRCL) Earnings History and Estimates Chart
Stericycle (NASDAQ SRCL) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/21/2018||Q4 2017||$1.14||$1.00||$882.62 million||$887.80 million||View||Listen|
|11/8/2017||Q3 2017||$1.14||$1.10||$896.81 million||$883.00 million||View||N/A|
|8/3/2017||Q2 2017||$1.13||$1.15||$902.81 million||$917.70 million||View||Listen|
|5/4/2017||Q1 2017||$1.05||$1.09||$874.34 million||$892.40 million||View||Listen|
|2/15/2017||Q416||$0.93||$1.00||$902.62 million||$906.40 million||View||Listen|
|10/27/2016||Q316||$1.17||$1.24||$899.87 million||$890.10 million||View||Listen|
|7/28/2016||Q216||$1.18||$1.18||$910.29 million||$891.60 million||View||Listen|
|4/28/2016||Q116||$1.15||$1.11||$871.54 million||$874.20 million||View||Listen|
|2/4/2016||Q415||$1.10||$1.11||$900.85 million||$888.30 million||View||N/A|
|10/22/2015||Q3||$1.19||$1.08||$735.47 million||$718.60 million||View||Listen|
|7/23/2015||Q2||$1.14||$1.14||$702.84 million||$715.70 million||View||Listen|
|4/23/2015||Q115||$1.10||$1.08||$676.43 million||$663.30 million||View||Listen|
|2/5/2015||Q414||$1.12||$1.12||$685.25 million||$676.90 million||View||Listen|
|10/23/2014||Q3||$1.06||$1.08||$662.93 million||$667.90 million||View||Listen|
|7/24/2014||Q2||$1.03||$1.03||$633.95 million||$640.80 million||View||Listen|
|4/24/2014||Q1||$0.99||$1.04||$572.41 million||$570.00 million||View||Listen|
|2/5/2014||Q4||$0.96||$0.99||$566.15 million||$567.90 million||View||Listen|
|10/23/2013||Q313||$0.94||$0.96||$542.38 million||$534.60 million||View||Listen|
|7/24/2013||Q2 2013||$0.91||$0.93||$529.08 million||$526.50 million||View||Listen|
|4/24/2013||Q1 2013||$0.88||$0.88||$519.58 million||$513.80 million||View||Listen|
|2/6/2013||Q4 2012||$0.86||$0.88||$491.37 million||$503.63 million||View||Listen|
|10/24/2012||Q312||$0.82||$0.84||$477.44 million||$480.50 million||View||N/A|
Stericycle (NASDAQ:SRCL) Earnings Estimates
2018 EPS Consensus Estimate: $4.65
2019 EPS Consensus Estimate: $4.63
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Stericycle (NASDAQ:SRCL)
No dividend announcements for this company have been tracked by MarketBeat.com
Stericycle (NASDAQ SRCL) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.50%
Institutional Ownership Percentage: 94.24%
Stericycle (NASDAQ SRCL) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/1/2018||Jack W Schuler||Director||Buy||10,000||$62.59||$625,900.00|| |
|12/4/2017||Mark C Miller||Director||Sell||19,753||$67.43||$1,331,944.79|| |
|11/27/2017||Mark C Miller||Director||Sell||19,753||$63.33||$1,250,957.49||205,854|| |
|11/13/2017||Mark C Miller||Director||Sell||19,753||$64.03||$1,264,784.59|| |
|10/30/2017||Mark C Miller||Director||Sell||19,753||$70.52||$1,392,981.56||205,576|| |
|2/23/2017||Mike S Zafirovski||Director||Buy||2,920||$85.67||$250,156.40||2,920|| |
|2/1/2017||Robert S Murley||Director||Buy||1,000||$76.22||$76,220.00|| |
|12/13/2016||Mark C Miller||Director||Sell||6,677||$76.23||$508,987.71||216,126|| |
|9/14/2016||John P Schetz||EVP||Sell||1,398||$81.85||$114,426.30||1,088|| |
|8/17/2016||Rodney F Dammeyer||Director||Sell||10,188||$85.50||$871,074.00||10,188|| |
|7/8/2016||Mark C Miller||Director||Sell||34,835||$104.52||$3,640,954.20||244,284|| |
|7/1/2016||Mark C Miller||Director||Sell||24,665||$104.55||$2,578,725.75||229,449|| |
|6/15/2016||Mark C Miller||Director||Sell||25,000||$101.12||$2,528,000.00||232,786|| |
|2/22/2016||Daniel Ginnetti||CFO||Sell||17,184||$110.67||$1,901,753.28||10,611|| |
|12/11/2015||John P. Schetz||EVP||Sell||1,190||$116.34||$138,444.60||383|| |
|8/18/2015||Rodney F Dammeyer||Director||Sell||8,500||$147.44||$1,253,240.00|| |
|6/3/2015||John P Schetz||Insider||Sell||2,150||$137.47||$295,560.50|| |
|2/20/2015||Michael J Collins||EVP||Sell||25,000||$133.87||$3,346,750.00|| |
|2/17/2015||Brent Arnold||COO||Sell||4,000||$132.91||$531,640.00|| |
|2/17/2015||Daniel Ginnetti||CFO||Sell||5,000||$132.86||$664,300.00|| |
|2/12/2015||Charles A Alutto||CEO||Sell||9,000||$132.02||$1,188,180.00|| |
|12/30/2014||Rodney F Dammeyer||Director||Sell||9,500||$132.60||$1,259,700.00|| |
|12/10/2014||John Patience||Director||Sell||65,124||$130.75||$8,514,963.00|| |
|10/31/2014||Daniel Ginnetti||CFO||Sell||5,000||$125.05||$625,250.00|| |
|10/30/2014||Brent Arnold||EVP||Sell||1,750||$123.61||$216,317.50|| |
|10/28/2014||Richard T Kogler||COO||Sell||26,437||$123.51||$3,265,233.87|| |
|10/27/2014||Brent Arnold||EVP||Sell||3,000||$123.06||$369,180.00|| |
|10/27/2014||Mark C Miller||Chairman||Sell||40,000||$122.61||$4,904,400.00|| |
|10/27/2014||Richard T Kogler||COO||Sell||12,500||$123.09||$1,538,625.00|| |
|8/19/2014||Charles A Alutto||CEO||Sell||16,500||$119.33||$1,968,945.00|| |
|7/29/2014||Brink Frank Jm Ten||CFO||Sell||45,000||$118.84||$5,347,800.00|| |
|7/29/2014||Richard T Kogler||COO||Sell||15,000||$119.35||$1,790,250.00|| |
|6/10/2014||William K Hall||Director||Sell||16,466||$115.69||$1,904,951.54|| |
|4/30/2014||Brink Frank Jm Ten||CFO||Sell||30,000||$116.09||$3,482,700.00||25,353|| |
|4/30/2014||Richard Kogler||COO||Sell||8,750||$116.12||$1,016,050.00||3,141|| |
|2/14/2014||Brink Frank Jm Ten||CFO||Sell||16,574||$116.18||$1,925,567.32||25,353|| |
|2/14/2014||Richard Kogler||COO||Sell||14,958||$116.18||$1,737,820.44||11,891|| |
|2/13/2014||Rodney Dammeyer||Director||Sell||20,000||$115.76||$2,315,200.00||7,500|| |
|2/12/2014||Brink Frank Jm Ten||CFO||Sell||10,202||$116.04||$1,183,840.08||25,353|| |
|2/12/2014||Richard Kogler||COO||Sell||9,608||$116.04||$1,114,912.32||11,891|| |
|12/20/2013||Jack Schuler||Director||Sell||6,452||$96.40||$621,972.80||720,179|| |
|12/10/2013||Mark Miller||Chairman||Sell||52,538||$115.68||$6,077,595.84||231,206|| |
|11/14/2013||Mark Miller||Chairman||Sell||13,000||$117.50||$1,527,500.00||231,636|| |
|11/4/2013||Brink Frank Jm Ten||CFO||Sell||18,274||$116.68||$2,132,210.32|| |
|11/4/2013||Richard T Kogler||COO||Sell||9,002||$116.65||$1,050,083.30|| |
|8/1/2013||Brink Frank Jm Ten||CFO||Sell||45,859||$116.35||$5,335,694.65|| |
|8/1/2013||Richard T Kogler||COO||Sell||5,000||$116.57||$582,850.00|| |
|7/31/2013||Michael J Collins||EVP||Sell||30,119||$116.25||$3,501,333.75|| |
|7/30/2013||Richard T Kogler||COO||Sell||30,000||$116.00||$3,480,000.00|| |
|7/30/2013||William K Hall||Director||Sell||12,529||$115.62||$1,448,602.98|| |
|6/28/2013||Jonathan T Md Lord||Director||Sell||6,040||$110.00||$664,400.00|| |
|6/13/2013||Jack W Schuler||Director||Sell||1,892||$105.75||$200,079.00|| |
|6/7/2013||John Patience||Director||Sell||45,500||$108.20||$4,923,100.00|| |
|8/8/2012||Ronald G Spaeth||Director||Sell||7,033||$89.43||$628,961.19|| |
Stericycle (NASDAQ SRCL) News Headlines
Stericycle (NASDAQ:SRCL) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Stericycle (NASDAQ:SRCL) Income Statement, Balance Sheet and Cash Flow Statement
Stericycle (NASDAQ SRCL) Stock Chart for Sunday, March, 18, 2018